Summary
Signal counts
Assets tracked: 2
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Fujian Cancer Hospital
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT06331845 | https://clinicaltrials.gov/study/NCT01164228 | https://clinicaltrials.gov/study/NCT02481635 | https://clinicaltrials.gov/study/NCT07243418
Assets
Linked programs
- Gemcitabine: Results Not Found Signal (4/5)
- herombopag olamine tablets: Low Signal (0/5)